Characterization of a human 5‐hydroxytryptamine3 receptor type A (h5‐HT3R‐AS) subunit stably expressed in HEK 293 cells

Anthony G. Hope, John A. Peters, Angus M. Brown, Jeremy J. Lambert, Thomas P. Blackburn

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

1. A cloned cDNA encoding a human 5-hydroxytryptamine receptor type A subunit (h5-HT3R-A(s)) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high density of the recombinant receptor was selected. 2. Membrane homogenates prepared from transfected, but not untransfected, cells exhibited a homogeneous and saturable population (B(max) = 4.49 ± 0.46 pmol mg-1 protein) of sites that bound the radiolabelled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pK(D) = 8.87 ± 0.08). Kinetic studies (at 37°C) revealed rapid association (κ+1 = 4.76 ± 0.3 x 108 M-1 min-1) and dissociation (κ-1 = 0.21 ± 0.003 min-1) of the radioligand. 3. Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > meta-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS. 4. In electrophysiological recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 μM) evoked transient inward current responses that reversed in sign at a potential of -1.0 ± 1.1 mV. Such responses were antagonized in a reversible manner by granisetron (1 nM). 5. The construction of a stable cell line expressing a high density of recombinant human 5-HT3 receptors which display appropriate pharmacology and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacology.

Original languageEnglish
Pages (from-to)1237-1245
Number of pages9
JournalBritish Journal of Pharmacology
Volume118
Issue number5
DOIs
Publication statusPublished - Jul 1996

Fingerprint

Receptors, Serotonin, 5-HT3
HEK293 Cells
Granisetron
Serotonin
Pharmacology
Serotonin 5-HT3 Receptor Antagonists
Cell Line
Ondansetron
Tubocurarine
Metoclopramide
Serotonin Receptors
Cocaine
Complementary DNA
Cell Culture Techniques
Ligands
Kidney
Membranes
Population
Proteins

Keywords

  • (+)-tubocurarine
  • 5-hydroxytryptamine
  • 5-hydroxytryptamine type A receptor subunit
  • HEK 293 cells
  • [H]-granisetron

Cite this

@article{ede513008f4c4a7796c9d10b627fe026,
title = "Characterization of a human 5‐hydroxytryptamine3 receptor type A (h5‐HT3R‐AS) subunit stably expressed in HEK 293 cells",
abstract = "1. A cloned cDNA encoding a human 5-hydroxytryptamine receptor type A subunit (h5-HT3R-A(s)) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high density of the recombinant receptor was selected. 2. Membrane homogenates prepared from transfected, but not untransfected, cells exhibited a homogeneous and saturable population (B(max) = 4.49 ± 0.46 pmol mg-1 protein) of sites that bound the radiolabelled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pK(D) = 8.87 ± 0.08). Kinetic studies (at 37°C) revealed rapid association (κ+1 = 4.76 ± 0.3 x 108 M-1 min-1) and dissociation (κ-1 = 0.21 ± 0.003 min-1) of the radioligand. 3. Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > meta-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS. 4. In electrophysiological recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 μM) evoked transient inward current responses that reversed in sign at a potential of -1.0 ± 1.1 mV. Such responses were antagonized in a reversible manner by granisetron (1 nM). 5. The construction of a stable cell line expressing a high density of recombinant human 5-HT3 receptors which display appropriate pharmacology and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacology.",
keywords = "(+)-tubocurarine, 5-hydroxytryptamine, 5-hydroxytryptamine type A receptor subunit, HEK 293 cells, [H]-granisetron",
author = "Hope, {Anthony G.} and Peters, {John A.} and Brown, {Angus M.} and Lambert, {Jeremy J.} and Blackburn, {Thomas P.}",
year = "1996",
month = "7",
doi = "10.1111/j.1476-5381.1996.tb15529.x",
language = "English",
volume = "118",
pages = "1237--1245",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley",
number = "5",

}

Characterization of a human 5‐hydroxytryptamine3 receptor type A (h5‐HT3R‐AS) subunit stably expressed in HEK 293 cells. / Hope, Anthony G.; Peters, John A.; Brown, Angus M.; Lambert, Jeremy J.; Blackburn, Thomas P.

In: British Journal of Pharmacology, Vol. 118, No. 5, 07.1996, p. 1237-1245.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Characterization of a human 5‐hydroxytryptamine3 receptor type A (h5‐HT3R‐AS) subunit stably expressed in HEK 293 cells

AU - Hope, Anthony G.

AU - Peters, John A.

AU - Brown, Angus M.

AU - Lambert, Jeremy J.

AU - Blackburn, Thomas P.

PY - 1996/7

Y1 - 1996/7

N2 - 1. A cloned cDNA encoding a human 5-hydroxytryptamine receptor type A subunit (h5-HT3R-A(s)) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high density of the recombinant receptor was selected. 2. Membrane homogenates prepared from transfected, but not untransfected, cells exhibited a homogeneous and saturable population (B(max) = 4.49 ± 0.46 pmol mg-1 protein) of sites that bound the radiolabelled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pK(D) = 8.87 ± 0.08). Kinetic studies (at 37°C) revealed rapid association (κ+1 = 4.76 ± 0.3 x 108 M-1 min-1) and dissociation (κ-1 = 0.21 ± 0.003 min-1) of the radioligand. 3. Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > meta-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS. 4. In electrophysiological recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 μM) evoked transient inward current responses that reversed in sign at a potential of -1.0 ± 1.1 mV. Such responses were antagonized in a reversible manner by granisetron (1 nM). 5. The construction of a stable cell line expressing a high density of recombinant human 5-HT3 receptors which display appropriate pharmacology and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacology.

AB - 1. A cloned cDNA encoding a human 5-hydroxytryptamine receptor type A subunit (h5-HT3R-A(s)) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high density of the recombinant receptor was selected. 2. Membrane homogenates prepared from transfected, but not untransfected, cells exhibited a homogeneous and saturable population (B(max) = 4.49 ± 0.46 pmol mg-1 protein) of sites that bound the radiolabelled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pK(D) = 8.87 ± 0.08). Kinetic studies (at 37°C) revealed rapid association (κ+1 = 4.76 ± 0.3 x 108 M-1 min-1) and dissociation (κ-1 = 0.21 ± 0.003 min-1) of the radioligand. 3. Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > meta-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS. 4. In electrophysiological recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 μM) evoked transient inward current responses that reversed in sign at a potential of -1.0 ± 1.1 mV. Such responses were antagonized in a reversible manner by granisetron (1 nM). 5. The construction of a stable cell line expressing a high density of recombinant human 5-HT3 receptors which display appropriate pharmacology and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacology.

KW - (+)-tubocurarine

KW - 5-hydroxytryptamine

KW - 5-hydroxytryptamine type A receptor subunit

KW - HEK 293 cells

KW - [H]-granisetron

U2 - 10.1111/j.1476-5381.1996.tb15529.x

DO - 10.1111/j.1476-5381.1996.tb15529.x

M3 - Article

C2 - 8818349

AN - SCOPUS:0030018192

VL - 118

SP - 1237

EP - 1245

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 5

ER -